<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1454" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1454/" /><meta name="ncbi_pagename" content="Alkaptonuria - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Alkaptonuria - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Alkaptonuria" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/05/12" /><meta name="citation_author" content="Wendy J Introne" /><meta name="citation_author" content="William A Gahl" /><meta name="citation_pmid" content="20301627" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1454/" /><meta name="citation_keywords" content="Alcaptonuria" /><meta name="citation_keywords" content="Alcaptonuria" /><meta name="citation_keywords" content="Homogentisate 1,2-dioxygenase" /><meta name="citation_keywords" content="HGD" /><meta name="citation_keywords" content="Alkaptonuria" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Alkaptonuria" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Wendy J Introne" /><meta name="DC.Contributor" content="William A Gahl" /><meta name="DC.Date" content="2016/05/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1454/" /><meta name="description" content="Alkaptonuria is caused by deficiency of homogentisate 1,2-dioxygenase, an enzyme that converts homogentisic acid (HGA) to maleylacetoacetic acid in the tyrosine degradation pathway. The three major features of alkaptonuria are the presence of HGA in the urine, ochronosis (bluish-black pigmentation in connective tissue), and arthritis of the spine and larger joints. Oxidation of the HGA excreted in the urine produces a melanin-like product and causes the urine to turn dark on standing. Ochronosis occurs only after age 30 years; arthritis often begins in the third decade. Other manifestations include pigment deposition, aortic or mitral valve calcification or regurgitation and occasionally aortic dilatation, renal stones, and prostate stones." /><meta name="og:title" content="Alkaptonuria" /><meta name="og:type" content="book" /><meta name="og:description" content="Alkaptonuria is caused by deficiency of homogentisate 1,2-dioxygenase, an enzyme that converts homogentisic acid (HGA) to maleylacetoacetic acid in the tyrosine degradation pathway. The three major features of alkaptonuria are the presence of HGA in the urine, ochronosis (bluish-black pigmentation in connective tissue), and arthritis of the spine and larger joints. Oxidation of the HGA excreted in the urine produces a melanin-like product and causes the urine to turn dark on standing. Ochronosis occurs only after age 30 years; arthritis often begins in the third decade. Other manifestations include pigment deposition, aortic or mitral valve calcification or regurgitation and occasionally aortic dilatation, renal stones, and prostate stones." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1454/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/alkap/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1454/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BB4CCE0413E510000000000BA0037.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1454_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1454_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alexander/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alpha1-a/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1454_"><span class="title" itemprop="name">Alkaptonuria</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Alcaptonuria</div><p class="contrib-group"><span itemprop="author">Wendy J Introne</span>, MD and <span itemprop="author">William A Gahl</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1454_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1454_ai__"><div class="contrib half_rhythm"><span itemprop="author">Wendy J Introne</span>, MD<div class="affiliation small">Staff Clinician, Office of the Clinical Director, National Human Genome Research Institute<br />National Institutes of Health<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.irghn@enortniw" class="oemail">vog.hin.irghn@enortniw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">William A Gahl</span>, MD, PhD<div class="affiliation small">Clinical Director, National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.xileh@lhagb" class="oemail">vog.hin.xileh@lhagb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 9, 2003</span>; Last Update: <span itemprop="dateModified">May 12, 2016</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="alkap.Summary" itemprop="description"><h2 id="_alkap_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Alkaptonuria is caused by deficiency of homogentisate 1,2-dioxygenase, an enzyme that converts homogentisic acid (HGA) to maleylacetoacetic acid in the tyrosine degradation pathway. The three major features of alkaptonuria are the presence of HGA in the urine, ochronosis (bluish-black pigmentation in connective tissue), and arthritis of the spine and larger joints. Oxidation of the HGA excreted in the urine produces a melanin-like product and causes the urine to turn dark on standing. Ochronosis occurs only after age 30 years; arthritis often begins in the third decade. Other manifestations include pigment deposition, aortic or mitral valve calcification or regurgitation and occasionally aortic dilatation, renal stones, and prostate stones.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of alkaptonuria is based on the detection of a significant amount of HGA in the urine by gas chromatography-mass spectrometry analysis. The amount of HGA excreted per day in individuals with alkaptonuria is usually between one and eight grams. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HGD</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> confirms the diagnosis and allows family studies.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management of joint pain tailored to the individual; physical and occupational therapy to help maintain muscle strength and flexibility; knee, hip, and shoulder replacements when needed; surgical intervention for prostate stones and renal stones as needed; aortic stenosis may necessitate valve replacement.</p><p><i>Surveillance:</i> In individuals older than age 40 years, echocardiography to detect aortic dilation, aortic or mitral valve calcification, and stenosis; CT to detect coronary artery calcification.</p><p><i>Agents/circumstances to avoid:</i> Physical stress to the spine and large joints, including heavy manual labor or high-impact sports, to try to reduce progression of severe arthritis.</p><p><i>Evaluation of relatives at risk:</i> Testing for the presence of elevated urinary HGA in sibs of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals allows for early diagnosis and intervention to prevent secondary complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Alkaptonuria is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both <i>HGD</i> pathogenic variants in the family are known.</p></div></div><div id="alkap.Diagnosis"><h2 id="_alkap_Diagnosis_">Diagnosis</h2><div id="alkap.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Alkaptonuria <b>should be suspected</b> in individuals with any of the following major features:</p><ul><li class="half_rhythm"><div><b>Dark urine or urine that turns dark on standing.</b> Oxidation of homogentisic acid (HGA) excreted in the urine produces a melanin-like product and causes the urine to turn dark on standing. Individuals with alkaptonuria usually have dark urine or urine that turns dark on standing or exposure to an alkaline agent. However, darkening may not occur for several hours after voiding and many individuals never observe any abnormal color to their urine.</div></li><li class="half_rhythm"><div><b>Ochronosis</b>
<b>(bluish-black pigmentation of connective tissue).</b> Accumulation of HGA and its oxidation products (e.g., benzoquinone acetic acid) in connective tissue leads to ochronosis (<a class="figpopup" href="/books/NBK1454/figure/alkap.F1/?report=objectonly" target="object" rid-figpopup="figalkapF1" rid-ob="figobalkapF1">Figure 1</a>).</div><ul><li class="half_rhythm"><div>Brown pigmentation of the sclera is observed midway between the cornea and the outer and inner canthi at the insertion of the recti muscles. Pigment deposition may also be seen in the conjunctiva and cornea. The pigmentation does not affect vision [<a class="bk_pop" href="#alkap.REF.ch_vez_barrios.2004.1060">Ch&#x000e9;vez Barrios &#x00026; Font 2004</a>].</div></li><li class="half_rhythm"><div>Ear cartilage pigmentation is seen in the concha and antihelix. The cartilage is slate blue or gray and feels irregular or thickened. Calcification of the ear cartilage may be observed on radiographs.</div></li><li class="half_rhythm"><div>Pigment also appears in cerumen and in perspiration, causing discoloration of clothing.</div></li><li class="half_rhythm"><div>A deep purple or black discoloration may be seen on the skin of the hands, corresponding to the underlying tendons, or in the web between the thumb and index finger.</div></li></ul></li><li class="half_rhythm"><div><b>Arthritis,</b> often beginning in the spine and resembling ankylosing spondylitis in its large-joint distribution. Radiographs of the spine showing flattened and calcified intervertebral disks are pathognomonic (<a class="figpopup" href="/books/NBK1454/figure/alkap.F1/?report=objectonly" target="object" rid-figpopup="figalkapF1" rid-ob="figobalkapF1">Figure 1</a>). Findings include degeneration of the intervertebral disks followed by disk calcification and eventually fusion of the vertebral bodies. Osteophyte formation and calcification of the intervertebral ligaments also occur. Radiographs of the large joints may show joint space narrowing, subchondral cysts, and osteophyte formation. Enthesopathy can be seen at the muscle insertions [<a class="bk_pop" href="#alkap.REF.mannoni.2004.239">Mannoni et al 2004</a>].</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figalkapF1" co-legend-rid="figlgndalkapF1"><a href="/books/NBK1454/figure/alkap.F1/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figalkapF1" rid-ob="figobalkapF1"><img class="small-thumb" src="/books/NBK1454/bin/alkap-Image001.gif" src-large="/books/NBK1454/bin/alkap-Image001.jpg" alt="Figure 1. A." /></a><div class="icnblk_cntnt" id="figlgndalkapF1"><h4 id="alkap.F1"><a href="/books/NBK1454/figure/alkap.F1/?report=objectonly" target="object" rid-ob="figobalkapF1">Figure 1</a></h4><p class="float-caption no_bottom_margin">A. Ochronosis of the sclera of the eye B. Ochronosis of the antihelix and concha</p></div></div></div><div id="alkap.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of alkaptonuria <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following:</p><div id="alkap.Biochemical_Findings"><h4>Biochemical Findings</h4><p><b>Elevated homogentisic acid (HGA) in the urine.</b> The diagnosis of alkaptonuria is based on the detection of a significant amount of HGA in a urine sample by gas chromatography-mass spectrometry analysis. The amount of HGA excreted per day in individuals with alkaptonuria is usually between one and eight grams. A normal 24-hour urine sample contains 20-30 mg of HGA.</p><p>Notes: (1) Elevated HGA can be detected on a random urine sample. (2) Biochemical testing cannot detect the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> state.</p></div><div id="alkap.Molecular_Genetic_Findings"><h4>Molecular Genetic Findings</h4><p>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HGD</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1454/table/alkap.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figalkapTmoleculargenetictestingusedi" rid-ob="figobalkapTmoleculargenetictestingusedi">Table 1</a>) is not required to establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. However, molecular genetic testing is needed in order to provide <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> and prenatal test result interpretation for at-risk family members.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>HGD</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Note: Targeted analysis for pathogenic variants may be performed first in individuals of Slovak ancestry. Pathogenic variants included in a panel may vary by laboratory.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, genome sequencing, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of alkaptonuria.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="alkap.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Alkaptonuria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1454/table/alkap.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alkap.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>HGD</i></td><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%</td></tr><tr><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_alkap.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;80%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="alkap.TF.1.1"><p class="no_margin">See <a href="/books/NBK1454/#alkap.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="alkap.TF.1.2"><p class="no_margin">See <a href="#alkap.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="alkap.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice-site variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="alkap.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="alkap.TF.1.5"><p class="no_margin">To date, only two individuals with deletions involving <i>HGD</i> have been reported [<a class="bk_pop" href="#alkap.REF.zouheir_habbal.2014.e106948">Zouheir Habbal et al 2014</a>, <a class="bk_pop" href="#alkap.REF.nemethova.2016.66">Nemethova et al 2016</a>].</p></div></dd><dt>6. </dt><dd><div id="alkap.TF.1.6"><p class="no_margin">Four pathogenic variants (<a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.481G&#x0003e;A</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.457dup</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.808G&#x0003e;A</a>, and <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.1111dup</a>) represent Slovak founder variants, accounting for 80% of all pathogenic variants found in the Slovak population. Six pathogenic variants <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.688C&#x0003e;T</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.899T&#x0003e;G</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.174delA</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.16-1G&#x0003e;A</a>, <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.342+1G&#x0003e;A</a>, and <a class="figpopup" href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figalkapTselectedhgdpathogenicvariants" rid-ob="figobalkapTselectedhgdpathogenicvariants">c.140C&#x0003e;T</a> are common in other populations, but rare in the Slovak population.</p></div></dd></dl></div></div></div></div></div></div><div id="alkap.Clinical_Characteristics"><h2 id="_alkap_Clinical_Characteristics_">Clinical Characteristics</h2><div id="alkap.Clinical_Description"><h3>Clinical Description</h3><p>The clinical findings of alkaptonuria include darkening of urine on standing as a result of the presence of homogentisic acid (HGA) and its oxidation products, connective tissue ochronosis, and arthritis of the spine and larger joints. HGA excretion and disease severity can vary significantly within the same family. In some individuals, the diagnosis of alkaptonuria is identified only after the individual seeks medical attention for chronic joint pain or after black articular cartilage is noted during orthopedic surgery.</p><p>Alkaptonuria does not cause developmental delay or cognitive impairment and does not generally reduce the life span of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Urinary changes.</b> Individuals with alkaptonuria usually have dark urine or urine that turns dark on standing or exposure to an alkaline agent. However, darkening may not occur for several hours after voiding and many individuals never observe any abnormal color to their urine.</p><p><b>Connective tissue.</b> In general, pigmentary changes are observed after age 30 years. Tendon-related findings, including a thickened Achilles tendon, tendonitis, and rupture, have also been observed clinically [<a class="bk_pop" href="#alkap.REF.phornphutkul.2002.2111">Phornphutkul et al 2002</a>] and are demonstrable by MRI.</p><p><b>Joints.</b> Ochronotic arthritis is a regular manifestation of longstanding alkaptonuria. Joint symptoms involving the spine usually appear in the third decade. In one large series, low back pain was observed prior to age 30 years in 49% of individuals and prior to age 40 years in 94% [<a class="bk_pop" href="#alkap.REF.phornphutkul.2002.2111">Phornphutkul et al 2002</a>].</p><p>Lumbar and thoracic spine symptoms precede cervical spine symptoms. The sacroiliac region is usually spared. Limitation of spine flexion directly correlates with degree of disability. Individuals with decreased forward flexion demonstrate impaired function and increased fatigue [<a class="bk_pop" href="#alkap.REF.perry.2006.2280">Perry et al 2006</a>].</p><p>Joint disease appears to start earlier and progress more rapidly in males than in females. Knees, hips, and shoulders are frequently affected. Fifty percent of individuals require at least one joint replacement by age 55 years [<a class="bk_pop" href="#alkap.REF.phornphutkul.2002.2111">Phornphutkul et al 2002</a>]. Small joint involvement is not significant.</p><p>Because the kidneys are responsible for secreting massive quantities of HGA, impaired renal function can accelerate the development of ochronosis and joint destruction [<a class="bk_pop" href="#alkap.REF.introne.2002.136">Introne et al 2002</a>].</p><p><b>Other organ involvement</b></p><ul><li class="half_rhythm"><div><b>Heart.</b> Pigment deposition in the heart valves and blood vessels leads to aortic or mitral valve calcification with stenosis or regurgitation and occasionally aortic dilatation. Aortic valve stenosis occurs at a high frequency in the sixth and seventh decades of life. Unlike cardiac valve disease that occurs in the general population, there is no correlation with standard cardiovascular risk factors. Aortic stenosis may necessitate aortic valve replacement. Coronary artery calcification has been demonstrated on chest CT [<a class="bk_pop" href="#alkap.REF.hannoush.2012.198">Hannoush et al 2012</a>].</div></li><li class="half_rhythm"><div><b>Renal stones.</b> By age 64 years, 50% of individuals with alkaptonuria have a history of renal stones.</div></li><li class="half_rhythm"><div><b>Prostate stones.</b> Black prostate stones occur relatively frequently in individuals with alkaptonuria. In one series, eight of 27 men age 31-60 years had prostate stones. Prostate stones may contribute to recurrent infection or urinary obstruction and require surgical removal.</div></li></ul></div><div id="alkap.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No correlation is observed between the type of <i>HGD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and amount of HGA excreted or disease severity.</p></div><div id="alkap.Penetrance"><h3>Penetrance</h3><p>Elevated urinary HGA and ochronotic arthritis occur in all individuals who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for pathogenic variants in <i>HGD</i>.</p></div><div id="alkap.Nomenclature"><h3>Nomenclature</h3><p>Occasionally alkaptonuria is referred to collectively (and incorrectly) as ochronosis.</p></div><div id="alkap.Prevalence"><h3>Prevalence</h3><p>At least 1000 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been described in the literature; this is likely an underestimate. The incidence of alkaptonuria in the US is estimated at 1:250,000 to 1:1,000,000 live births.</p><p>Alkaptonuria occurs worldwide; a high prevalence has been observed in the Dominican Republic and in northwestern Slovakia, likely as the result of a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a>. The prevalence of alkaptonuria in Slovakia is estimated at 1:19,000 [<a class="bk_pop" href="#alkap.REF.zatkova.2003.145">Zatkova et al 2003</a>].</p></div></div><div id="alkap.Genetically_Related_Allelic_Disord"><h2 id="_alkap_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are associated with pathogenic variants in <i>HGD</i>.</p></div><div id="alkap.Differential_Diagnosis"><h2 id="_alkap_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Ochronosis.</b> Ochronosis resulting from alkaptonuria may be confused with acquired, reversible pigmentary changes following prolonged use of carbolic acid dressings for chronic cutaneous ulcers [<a class="bk_pop" href="#alkap.REF.la_du.2001">La Du 2001</a>]. Chemically induced ochronosis has also been described following long-term use of either the antimalarial agent Atabrine<sup>&#x000ae;</sup> [<a class="bk_pop" href="#alkap.REF.ludwig.1963.378">Ludwig et al 1963</a>], the skin-lightening agent hydroquinone, or the antibiotic minocycline [<a class="bk_pop" href="#alkap.REF.suwannarat.2004.3698">Suwannarat et al 2004</a>].</p><p>In one individual with alkaptonuria, the ochronotic pigment in the eye was misdiagnosed as melanosarcoma, resulting in enucleation of the eye [<a class="bk_pop" href="#alkap.REF.skinsnes.1948.552">Skinsnes 1948</a>].</p><p>A thorough history combined with lack of excessive HGA excretion in the urine should eliminate false positive diagnoses.</p><p><b>Arthritis.</b> The arthritis of alkaptonuria resembles ankylosing spondylitis in its damage to the spine and large joints, although it differs in sparing the sacroiliac joint and in its radiographic appearance. Radiographic findings of the spine also differentiate alkaptonuria from rheumatoid arthritis and osteoarthritis.</p></div><div id="alkap.Management"><h2 id="_alkap_Management_">Management</h2><div id="alkap.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with alkaptonuria, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete history and physical examination with particular attention to range of motion in the spine and large joints</div></li><li class="half_rhythm"><div>Physical medicine and rehabilitation evaluation if limited range of motion or joint pain occurs</div></li><li class="half_rhythm"><div>Electrocardiogram and echocardiogram in individuals older than age 40 years</div></li><li class="half_rhythm"><div>Renal ultrasound examination or helical abdominal CT to evaluate for the presence of renal calculi</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="alkap.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Joint pain is substantial in individuals with alkaptonuria, and close attention to pain control is necessary. Optimal pain management should be tailored to the individual with close follow up and long-term management.</p><p>Physical and occupational therapy are important to promote optimal muscle strength and flexibility.</p><p>Knee, hip, and shoulder replacement surgeries are options for managing significant arthritis. In general, the goal of joint replacement is pain relief rather than increased range of motion. Joint replacement in individuals with alkaptonuria is associated with prosthetic survival comparable to that found in individuals with osteoarthritis [<a class="bk_pop" href="#alkap.REF.spencer.2004.355">Spencer et al 2004</a>].</p><p>Aortic stenosis may necessitate valve replacement.</p><p>Treatment of prostate stones and renal stones may include surgical intervention.</p></div><div id="alkap.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>Although several therapeutic modalities have been investigated, no preventive or curative treatment is available. See <a href="#alkap.Therapies_Under_Investigation">Therapies Under Investigation</a>.</p></div><div id="alkap.Prevention_of_Secondary_Manifestat"><h3>Prevention of Secondary Manifestations</h3><p>Maintaining joint range of motion through moderate non-weight-bearing exercise such as swimming may have beneficial effects.</p><p>Younger individuals with alkaptonuria should be directed toward non-contact and lower-impact sports.</p></div><div id="alkap.Surveillance"><h3>Surveillance</h3><p><b>Cardiac.</b> Surveillance for cardiac complications every one to two years is advisable after age 40 years and should include:</p><ul><li class="half_rhythm"><div>Echocardiography to detect aortic dilation and aortic or mitral valve calcification and stenosis;</div></li><li class="half_rhythm"><div>Surveillance CT scans (according to the recommendation of a cardiologist) in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with coronary artery calcification.</div></li></ul><p><b>Urology.</b> Urologic complications become more prevalent after age 40 years:</p><ul><li class="half_rhythm"><div>Routine surveillance is not recommended, but awareness of this potential complication is advised.</div></li><li class="half_rhythm"><div>Ochronotic prostate stones appear on radiography; kidney stones can be identified by ultrasonography and helical abdominal CT.</div></li></ul></div><div id="alkap.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoidance of physical stress to the spine and large joints, including heavy manual labor or high-impact sports, may reduce the progression of severe arthritis.</p></div><div id="alkap.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from preventive measures. Those found to have alkaptonuria should be counseled to avoid high-impact and contact sports. Career considerations include avoidance of occupations involving heavy physical labor. Instruction on joint strengthening and flexibility exercises, in conjunction with appropriate physical activity, can help preserve overall joint mobility and function.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Biochemical testing for the presence of elevated urinary homogentisic acid (HGA).</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known.</div></li></ul><p>See <a href="#alkap.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="alkap.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Pharmacologic treatment of alkaptonuria with oral administration of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) or nitisinone has been proposed [<a class="bk_pop" href="#alkap.REF.anikster.1998.920">Anikster et al 1998</a>]. Nitisinone is a triketone herbicide that inhibits 4-hydroxyphenylpyruvate dioxygenase, the enzyme that produces HGA. Nitisinone is approved for the treatment of <a href="/books/n/gene/tyrosinemia/">tyrosinemia type I</a>.</p><p>Nitisinone reduced urinary HGA excretion by at least 69% in two individuals, but at the expense of an elevated plasma tyrosine concentration [<a class="bk_pop" href="#alkap.REF.phornphutkul.2002.2111">Phornphutkul et al 2002</a>], resulting in photophobia. The only other known side effect is (rarely) corneal crystals. Theoretically, neurologic complications associated with tyrosinemia type III may develop.</p><p>In a pilot study, low-dose nitisinone reduced urinary HGA by up to 95% in nine individuals with alkaptonuria. In the same study, seven individuals were treated for up to 15 weeks with nitisinone while receiving normal protein intake; all had elevated plasma tyrosine concentrations. No ophthalmic, neurologic, or severe dermatologic complications were observed. Two individuals had transient elevations in liver transaminase levels that returned to normal after stopping nitisinone [<a class="bk_pop" href="#alkap.REF.suwannarat.2005.719">Suwannarat et al 2005</a>].</p><p>In a three-year therapeutic trial, 2 mg of nitisinone daily reduced urine and plasma HGA by 95% throughout the study duration [<a class="bk_pop" href="#alkap.REF.introne.2011.307">Introne et al 2011</a>]. Plasma tyrosine averaged 800&#x003bc;M without dietary restriction. Side effects were minimal. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual developed corneal crystals that required discontinuation of nitisinone, and one affected individual had elevated liver transaminases. Statistically significant improvement in hip range of motion and measurements of musculoskeletal function were not observed in the treatment group compared to the control group; however there was a positive trend showing slowing of aortic stenosis. Additional trials are currently underway to establish clinical benefit.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="alkap.Other"><h3>Other</h3><p>No therapy is proven to prevent or correct the pigmentary changes of ochronosis.</p><ul><li class="half_rhythm"><div>Dietary restriction of phenylalanine and tyrosine has been proposed to reduce the production of HGA, but severe restriction of these amino acids is not practical in the long term and may be dangerous.</div></li><li class="half_rhythm"><div>High-dose vitamin C decreases urinary benzoquinone acetic acid, a derivative of HGA, but has no effect on HGA excretion [<a class="bk_pop" href="#alkap.REF.wolff.1989.140">Wolff et al 1989</a>]. It has been hypothesized that high-dose ascorbic acid may prevent the deposition of ochronotic pigment, although it does not alter the basic metabolic defect [<a class="bk_pop" href="#alkap.REF.wolff.1989.140">Wolff et al 1989</a>]. No credible studies have demonstrated the clinical efficacy of ascorbic acid [<a class="bk_pop" href="#alkap.REF.la_du.2001">La Du 2001</a>].</div></li><li class="half_rhythm"><div>Oral bisphosphonate therapy has been suggested to halt the progressive bone loss; however, a prospective study of four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals failed to demonstrate benefit [<a class="bk_pop" href="#alkap.REF.aliberti.2007.729">Aliberti et al 2007</a>].</div></li></ul></div></div><div id="alkap.Genetic_Counseling"><h2 id="_alkap_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="alkap.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Alkaptonuria is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="alkap.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>HGD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with alkaptonuria are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>HGD</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>HGD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="alkap.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>HGD</i> pathogenic variants in the family.</p><p><b>Biochemical testing.</b> Biochemical genetic testing is not reliable as a method of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection.</p></div><div id="alkap.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#alkap.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="alkap.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>HGD</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for alkaptonuria are possible.</p><p><b>Biochemical testing.</b> In theory, homogentisic acid can be measured in amniotic fluid; however, no studies have been published to confirm the reliability of the test in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="alkap.Resources"><h2 id="_alkap_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alkaptonuria Society</b></div><div>66 Devonshire Road</div><div>Cambridge CB1 2BL</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0)1223 322897</div><div><a href="http://www.akusociety.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.akusociety.org</a></div></li><li class="half_rhythm"><div><b>Alkaptonuria: A Fact Sheet for Patients</b></div><div>National Institutes of Health</div><div><b>Phone:</b> 800-411-1222 (toll-free)</div><div><b>Email:</b> prpl@cc.nih.gov</div><div><a href="http://www.simd.org/Messages/Alkapto_fact_sheet.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alkaptonuria: A Fact Sheet for Patients (PDF file)</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001200.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alkaptonuria</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Alkaptonuria&#x00026;parent=Metabolic%20Disorders&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alkaptonuria</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=alkaptonuria" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alkaptonuria</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="alkap.Molecular_Genetics"><h2 id="_alkap_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="alkap.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Alkaptonuria: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1454/table/alkap.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alkap.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_alkap.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_alkap.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_alkap.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_alkap.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_alkap.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_alkap.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_alkap.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3081" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HGD</i></a></td><td headers="hd_b_alkap.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3081" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_alkap.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q93099" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Homogentisate 1,2-dioxygenase</a></td><td headers="hd_b_alkap.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.alkaptonuria.cib.csic.es/index.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKU database</a><br /><a href="http://hgddatabase.cvtisr.sk/home.php?select_db=HGD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGD mutation database</a><br /><a href="http://databases.lovd.nl/shared/genes/HGD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGD database</a></td><td headers="hd_b_alkap.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HGD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGD</a></td><td headers="hd_b_alkap.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HGD[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGD</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="alkap.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="alkap.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Alkaptonuria (<a href="/omim/203500,607474" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1454/table/alkap.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alkap.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/203500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">203500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALKAPTONURIA; AKU</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607474" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607474</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HOMOGENTISATE 1,2-DIOXYGENASE; HGD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>HGD</i> is 54.3 kb in length and has 14 exons coding for a 1715-bp transcript [<a class="bk_pop" href="#alkap.REF.granadino.1997.115">Granadino et al 1997</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1454/#alkap.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> At least 130 pathogenic variants in <i>HGD</i> have been reported and are found in different allelic combinations [<a href="http://hgddatabase.cvtisr.sk/home.php?select_db=HGD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGD mutation database</a>]. The pathogenic variants are distributed throughout the <i>HGD</i> sequence. The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>; <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frame shift, and splice-site variants also occur.</p><ul><li class="half_rhythm"><div>p.Cys120Trp is a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in the Dominican Republic [<a class="bk_pop" href="#alkap.REF.goicoechea_de_jorge.2002.e40">Goicoechea De Jorge et al 2002</a>].</div></li><li class="half_rhythm"><div>In the Slovak population, evidence exists for mutational hot spots (e.g., c.342+1G&#x0003e;A [<a class="bk_pop" href="#alkap.REF.zatkov_.2000.1333">Zatkov&#x000e1; et al 2000</a>]) and a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> (e.g., the frequent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Gly161Arg [<a class="bk_pop" href="#alkap.REF.srsen.2002.353">Srsen et al 2002</a>]).</div></li><li class="half_rhythm"><div>The most prevalent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in Europe (excluding the Slovak population) is c.1102A&#x0003e;G (p.Met368Val).</div></li><li class="half_rhythm"><div>No mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> or <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> has been identified in the US [<a class="bk_pop" href="#alkap.REF.phornphutkul.2002.2111">Phornphutkul et al 2002</a>].</div></li></ul><div id="alkap.T.selected_hgd_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>HGD</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1454/table/alkap.T.selected_hgd_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alkap.T.selected_hgd_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change (Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.140C&#x0003e;T</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser47Leu</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_3" rowspan="12" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000187.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000187<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000178.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000178<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.16-1G&#x0003e;A<br />(IVS1-1G&#x0003e;A)</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr6_Gln29del</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.174delA</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser59AlafsTer52<br />(Ser59AlafsTer31) (R58fs)</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.360T&#x0003e;G</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys120Trp</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.342+1G&#x0003e;A<br />(IVS5+1G&#x0003e;A)</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu95_Ser114del</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.457dup</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp153GlyfsTer26<br />(Gly152fs)</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.481G&#x0003e;A</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly161Arg</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.688C&#x0003e;T</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro230Ser</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.808G&#x0003e;A</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly270Arg</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.899T&#x0003e;G</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val300Gly</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1102A&#x0003e;G</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met368Val</td></tr><tr><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1111dup<br />(111_1112insC)</td><td headers="hd_h_alkap.T.selected_hgd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His371ProfsTer4<br />(Pro370fs)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="alkap.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein product of <i>HGD</i> is homogentisate 1,2-dioxygenase, an enzyme in the phenylalanine and tyrosine degradation pathway (see <a class="figpopup" href="/books/NBK1454/figure/alkap.F2/?report=objectonly" target="object" rid-figpopup="figalkapF2" rid-ob="figobalkapF2">Figure 2</a>). The enzyme is composed of 445 amino acids and is expressed predominantly in the liver and kidney, with some expression in the small intestine, colon, and prostate [<a class="bk_pop" href="#alkap.REF.fern_ndezca__n.1996.19">Fern&#x000e1;ndez-Ca&#x000f1;&#x000f3;n et al 1996</a>]. Homogentisate 1,2-dioxygenase functions in the metabolism of HGA by catalyzing an oxidative cleavage of the benzene ring to yield maleylacetoacetic acid. It requires oxygen, ferrous iron, and sulfhydryl groups.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figalkapF2" co-legend-rid="figlgndalkapF2"><a href="/books/NBK1454/figure/alkap.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figalkapF2" rid-ob="figobalkapF2"><img class="small-thumb" src="/books/NBK1454/bin/alkap-Image002.gif" src-large="/books/NBK1454/bin/alkap-Image002.jpg" alt="Figure 2. . The tyrosine degradation pathway." /></a><div class="icnblk_cntnt" id="figlgndalkapF2"><h4 id="alkap.F2"><a href="/books/NBK1454/figure/alkap.F2/?report=objectonly" target="object" rid-ob="figobalkapF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">The tyrosine degradation pathway. Alkaptonuria is characterized by deficiency of homogentisate 1,2-dioxygenase, which converts homogentisic acid (HGA) to maleylacetoacetic acid. </p></div></div><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most mutated <i>HGD</i> alleles are predicted to result in complete loss of enzymatic activity.</p></div><div id="alkap.References"><h2 id="_alkap_References_">References</h2><div id="alkap.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.aliberti.2007.729">Aliberti G, Pulignano I, Pisani D, Rocchietti March M, Del Porto F, Proietta M. Bisphosphonate treatment in ochronotic osteoporotic patients. <span><span class="ref-journal">Clin Rheumatol. </span>2007;<span class="ref-vol">26</span>:729–35.</span> [<a href="/pubmed/16924393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16924393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.anikster.1998.920">Anikster Y, Nyhan WL, Gahl WA. NTBC and alkaptonuria. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:920–1.</span> [<a href="/pmc/articles/PMC1377415/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377415</span></a>] [<a href="/pubmed/9718357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9718357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.ch_vez_barrios.2004.1060">Ch&#x000e9;vez Barrios P, Font RL. Pigmented conjunctival lesions as initial manifestation of ochronosis. <span><span class="ref-journal">Arch Ophthalmol. </span>2004 Jul;<span class="ref-vol">122</span>(7):1060–3.</span> [<a href="/pubmed/15249376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15249376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.fern_ndezca__n.1996.19">Fern&#x000e1;ndez-Ca&#x000f1;&#x000f3;n JM, Granadino B, Beltr&#x000e1;n-Valero de Bernab&#x000e9; D, Renedo M, Fern&#x000e1;ndez-Ruiz E, Pe&#x000f1;alva MA, Rodr&#x000ed;guez de C&#x000f3;rdoba S. The molecular basis of alkaptonuria. <span><span class="ref-journal">Nat Genet. </span>1996 Sep;<span class="ref-vol">14</span>(1):19–24.</span> [<a href="/pubmed/8782815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8782815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.goicoechea_de_jorge.2002.e40">Goicoechea De Jorge E, Lorda I, Gallardo ME, P&#x000e9;rez B, Per&#x000e9;z De Ferr&#x000e1;n C, Mendoza H, Rodr&#x000ed;guez De C&#x000f3;rdoba S. Alkaptonuria in the Dominican Republic: identification of the founder AKU mutation and further evidence of mutation hot spots in the HGO gene. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:E40.</span> [<a href="/pmc/articles/PMC1735184/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735184</span></a>] [<a href="/pubmed/12114497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12114497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.granadino.1997.115">Granadino B, Beltran-Valero de Bernabe D, Fernandez-Canon JM, Penalva MA, Rodriguez de Cordoba S. The human homogentisate 1,2-dioxygenase (HGO) gene. <span><span class="ref-journal">Genomics. </span>1997;<span class="ref-vol">43</span>:115–22.</span> [<a href="/pubmed/9244427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9244427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.hannoush.2012.198">Hannoush H, Introne WJ, Chen MY, Lee S-J, O'Brien K, Suwannarat P, Kayser MA, Gahl WA, Sachdev V. Aortic stenosis and vascular calcifications in alkaptonuria. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">105</span>:198–202.</span> [<a href="/pmc/articles/PMC3276068/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276068</span></a>] [<a href="/pubmed/22100375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22100375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.introne.2011.307">Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, Suwannarat P, O'Brien KE, Bryant J, Sachdev V, Reynolds JC, Moylan E, Bernardini I, Gahl WA. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">103</span>:307–14.</span> [<a href="/pmc/articles/PMC3148330/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3148330</span></a>] [<a href="/pubmed/21620748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21620748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.introne.2002.136">Introne WJ, Phornphutkul C, Bernardini I, McLaughlin K, Fitzpatrick D, Gahl WA. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">77</span>:136–42.</span> [<a href="/pubmed/12359141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12359141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.la_du.2001">La Du BN. Alkaptonuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease.</em> 8 ed. New York, NY: McGraw-Hill; 2001:2109-23.</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.ludwig.1963.378">Ludwig GD, Toole JF, Wood JC. Ochronosis from quinacrine (atabrine). <span><span class="ref-journal">Ann Intern Med. </span>1963;<span class="ref-vol">59</span>:378–84.</span> [<a href="/pubmed/14065956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14065956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.mannoni.2004.239">Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airo P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B. Alkaptonuria, ochronosis, and ochronotic arthropathy. <span><span class="ref-journal">Semin Arthritis Rheum. </span>2004;<span class="ref-vol">33</span>:239–48.</span> [<a href="/pubmed/14978662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14978662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.nemethova.2016.66">Nemethova M, Radvanszky J, Kadasi L, Ascher DB, Pires DE, Blundell TL, Porfirio B, Mannoni A, Santucci A, Milucci L, Sestini S, Biolcati G, Sorge F, Aurizi C, Aquaron R, Alsbou M, Louren&#x000e7;o CM, Ramadevi K, Ranganath LR, Gallagher JA, van Kan C, Hall AK, Olsson B, Sireau N, Ayoob H, Timmis OG, Sang KH, Genovese F, Imrich R, Rovensky J, Srinivasaraghavan R, Bharadwaj SK, Spiegel R, Zatkova A. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on "black bone disease" in Italy. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:66–72.</span> [<a href="/pmc/articles/PMC4795215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4795215</span></a>] [<a href="/pubmed/25804398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25804398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.perry.2006.2280">Perry MB, Suwannarat P, Furst GP, Gahl WA, Gerber LH. Musculoskeletal findings and disability in alkaptonuria. <span><span class="ref-journal">J Rheumatol. </span>2006;<span class="ref-vol">33</span>:2280–5.</span> [<a href="/pubmed/16981292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16981292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.phornphutkul.2002.2111">Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL, Anderson PD, Huizing M, Anikster Y, Gerber LH, Gahl WA. Natural history of alkaptonuria. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:2111–21.</span> [<a href="/pubmed/12501223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12501223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.skinsnes.1948.552">Skinsnes OK. Generalized ochronosis; report of an instance in which it was misdiagnosed as melanosarcoma, with resultant enucleation of an eye. <span><span class="ref-journal">Arch Pathol (Chic). </span>1948;<span class="ref-vol">45</span>:552–8.</span> [<a href="/pubmed/18891026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18891026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.spencer.2004.355">Spencer JM, Gibbons CL, Sharp RJ, Carr AJ, Athanasou NA. Arthroplasty for ochronotic arthritis: no failure of 11 replacements in 3 patients followed 6-12 years. <span><span class="ref-journal">Acta Orthop Scand. </span>2004;<span class="ref-vol">75</span>:355–8.</span> [<a href="/pubmed/15260431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15260431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.srsen.2002.353">Srsen S, Muller CR, Fregin A, Srsnova K. Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">75</span>:353–9.</span> [<a href="/pubmed/12051967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12051967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.suwannarat.2005.719">Suwannarat P, O'Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI, Rubin BI, Tsilou E, Gerber LH, Gahl WA. Use of nitisinone in patients with alkaptonuria. <span><span class="ref-journal">Metabolism. </span>2005;<span class="ref-vol">54</span>:719–28.</span> [<a href="/pubmed/15931605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15931605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.suwannarat.2004.3698">Suwannarat P, Phornphutkul C, Bernardini I, Turner M, Gahl WA. Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain. <span><span class="ref-journal">Arthritis Rheum. </span>2004;<span class="ref-vol">50</span>:3698–701.</span> [<a href="/pubmed/15529343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15529343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.wolff.1989.140">Wolff JA, Barshop B, Nyhan WL, Leslie J, Seegmiller JE, Gruber H, Garst M, Winter S, Michals K, Matalon R. Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. <span><span class="ref-journal">Pediatr Res. </span>1989;<span class="ref-vol">26</span>:140–4.</span> [<a href="/pubmed/2771520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2771520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.zatkova.2003.145">Zatkova A, Chmelikova A, Polakova H, Ferakova E, Kadasi L. Rapid detection methods for five HGO gene mutations causing alkaptonuria. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">63</span>:145–9.</span> [<a href="/pubmed/12630963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12630963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.zatkov_.2000.1333">Zatkov&#x000e1; A, de Bernab&#x000e9; DB, Pol&#x000e1;kov&#x000e1; H, Zvar&#x000ed;k M, Fer&#x000e1;kov&#x000e1; E, Bos&#x000e1;k V, Fer&#x000e1;k V, K&#x000e1;dasi L, de C&#x000f3;rdoba SR. High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:1333–9.</span> [<a href="/pmc/articles/PMC1288576/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288576</span></a>] [<a href="/pubmed/11017803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11017803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alkap.REF.zouheir_habbal.2014.e106948">Zouheir Habbal M, Bou-Assi T, Zhu J, Owen R, Chehab FF. First report of a deletion encompassing an entire exon in the homogentisate 1,2-dioxygenase gene causing alkaptonuria. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e106948.</span> [<a href="/pmc/articles/PMC4169433/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4169433</span></a>] [<a href="/pubmed/25233259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25233259</span></a>]</div></li></ul></div></div><div id="alkap.Chapter_Notes"><h2 id="_alkap_Chapter_Notes_">Chapter Notes</h2><div id="alkap.Author_Notes"><h3>Author Notes</h3><p>Dr Introne is a pediatrician, clinical geneticist, and biochemical geneticist.</p><p>Dr Gahl is a pediatrician, clinical geneticist, and biochemical geneticist who performs clinical and basic research into rare diseases.</p></div><div id="alkap.Author_History"><h3>Author History</h3><p>William A Gahl, MD, PhD (2003-present) <br />Wendy J Introne, MD (2003-present) <br />Michael A Kayser, DO; Saint Francis Hospital, Tulsa (2007-2013) <br />Chanika Phornphutkul, MD; Brown University (2003-2007) <br />Pim Suwannarat, MD; Mahidol University (2003-2007)</p></div><div id="alkap.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 May 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 August 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 July 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically</div></li><li class="half_rhythm"><div>4 December 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 June 2006 (ca) Revision: <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> available for eight mutations</div></li><li class="half_rhythm"><div>24 May 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 May 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>4 March 2003 (ps) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Alkaptonuria" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1454</span><span class="label">PMID: <a href="/pubmed/20301627" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301627</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alexander/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alpha1-a/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1454&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1454/?report=reader">PubReader</a></li><li><a href="/books/NBK1454/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1454" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1454" style="display:none" title="Cite this Page"><div class="bk_tt">Introne WJ, Gahl WA. Alkaptonuria. 2003 May 9 [Updated 2016 May 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1454/pdf/Bookshelf_NBK1454.pdf">PDF version of this page</a> (564K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#alkap.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#alkap.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#alkap.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#alkap.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#alkap.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#alkap.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#alkap.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#alkap.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#alkap.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#alkap.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#alkap.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3081[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HGD</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1454+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1461894" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1461894" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1461894" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1461894" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24772955" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alkaptonuria: a very rare metabolic disorder.</a><span class="source">[Indian J Biochem Biophys. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alkaptonuria: a very rare metabolic disorder.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Aquaron R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Indian J Biochem Biophys. 2013 Oct; 50(5):339-44. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12501223" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Natural history of alkaptonuria.</a><span class="source">[N Engl J Med. 2002]</span><div class="brieflinkpop offscreen_noflow">Natural history of alkaptonuria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL, Anderson PD, Huizing M, Anikster Y, Gerber LH, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">N Engl J Med. 2002 Dec 26; 347(26):2111-21. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31600782" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.</a><span class="source">[Hum Mol Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hughes JH, Liu K, Plagge A, Wilson PJM, Sutherland H, Norman BP, Hughes AT, Keenan CM, Milan AM, Sakai T, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2019 Oct 10; . Epub 2019 Oct 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12359141" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.</a><span class="source">[Mol Genet Metab. 2002]</span><div class="brieflinkpop offscreen_noflow">Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Introne WJ, Phornphutkul C, Bernardini I, McLaughlin K, Fitzpatrick D, Gahl WA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2002 Sep-Oct; 77(1-2):136-42. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301627" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301627" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04155e39a66ee2ba061e8b">Alkaptonuria - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Alkaptonuria - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:05:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BB4CCE0413E510000000000BA0037&amp;ncbi_session=CE8BB4CCE04155D1_0186SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1454%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1454&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1454/&amp;ncbi_pagename=Alkaptonuria - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BB4CCE04155D1_0186SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>